Author

Richard J. Simpson

La Trobe UniversityORCID 0000-0002-9834-0796Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:non-human primate· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Adnan ShafiqiD· 1 shared Alin RaiiD· 1 shared Beverly A. MockiD· 1 shared Bih‐Rong Wei· 1 shared David W. GreeningiD· 1 shared Heather R. ShiveiD· 1 shared Maoshan CheniD· 1 shared Rong XuiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Adnan ShafiqORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Oncogenic H-Ras Reprograms Madin-Darby Canine Kidney (MDCK) Cell-derived Midbody Remnant Proteins Following Epithelial-Mesenchymal Transition

Adnan Shafiq, Alin Rai, Rong Xu, Maoshan Chen, Wittaya Suwakulsiri, David W. Greening, Richard J. Simpson

This study identifies proteomic changes in midbody remnants (MBRs) from MDCK cells and H-Ras-transformed cells during EMT, revealing distinct protein profiles associated with mesenchymal and epithelial states.

bioRxiv · Jul 17, 2025 · PreprintCell Biology

Capacity for compensatory cyclin D2 response confers trametinib resistance in canine mucosal melanoma

Bih‐Rong Wei, Vincenzo Verdi, Shuling Zhang, Beverly A. Mock, Heather R. Shive, Richard J. Simpson

This study identifies a compensatory cyclin D2 response as a mechanism conferring trametinib resistance in canine mucosal melanoma.

Cancers · Jul 15, 2025Peer-reviewedCancer Biology